Men who have a low PSA level according to standard PSA testing can still have prostate cancer, according to a recent study in the New England Journal of Medicine (2004; 350:2239-46).
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.